At a glance
- Originator sigma-tau SpA
- Class Nootropics; Pyrrolidines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 22 Jan 1997 No-Development-Reported for Cognition disorders (Unknown route)